Given the high mutation rate of ARID1A in several cancers, it is of clinical importance to know whether ARID1A loss correlates with the accumulation of unrepaired DNA damage, the level of immune regulatory cytokines, and the levels of tumor-infiltrating immune cells. Here, ARID1A is linked to neoplasm.